Clinical Trial Update: Focused Orticumab Research for Treating Inflammation in Coronary Arteries [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Orticumab targeting inflammation in coronary arteries; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• Orticumab (Orticumab)

Snippet

Sponsor: Abcentra | Conditions: Acute Coronary Syndromes, Coronary Arterial Disease (CAD) | Phase 2 | Status: RECRUITING